Ratnakar Securities Pvt. Ltd.

SOLARA ACTIVE PHARMA SCIENCES LTD.

NSE : SOLARABSE : 541540ISIN CODE : INE624Z01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE552.350.7 (+0.13 %)

PREV CLOSE ( ) 551.65

OPEN PRICE ( ) 558.35

BID PRICE (QTY) 552.35 (56)

OFFER PRICE (QTY) 554.40 (56)

VOLUME 8938

TODAY'S LOW / HIGH ( )544.35 559.00

52 WK LOW / HIGH ( )287 606.95

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 23-02 2017

Management Info

- Chairman Poorvank Purohit - Managing Director

Registered Office

Address 201, Devavrata,Sector 17,Vashi,
Navi Mumbai,
Maharashtra-400703

Phone 022 2789 2924 / 2789 3199

Email investors@solara.co.in

Website www.solara.co.in

Registrars Details

Cameo Corporate Services Ltd

Subramanian Buildings No 1 ,Club House Road,,Chennai

Listing : BSE, NSE

NEWS

22Apr Clarification sought from Solara Acti
The Exchange has sought clarification from Solara Active Pharma Sciences..

26Mar Solara Active Pharma Sciences gets nod
Solara Active Pharma Sciences has received approval from board of direct..

08Mar Solara Active Pharma Sciences informs
Pursuant to Section 110 of the Companies Act, 2013 read with the Compani..

08Mar Solara Active Pharma Sciences informs
Solara Active Pharma Sciences has informed that the Board in its meeting..

21Feb Solara Active Pharma Sciences informs
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	-2753.3	-222.099999999999
Gross Profit	-2753.3	-447.799999999999
Operating Profit	-1612.3	1561.8
Net Sales	2487.3	14438.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE) 2730.55 (4.18%)	M.Cap ( in Cr)1679.80
Vimta Labs (BSE) 574.60 (12.79%)	M.Cap ( in Cr)1259.29
Dr. Reddy's Lab (BSE) 6008.95 (0.97%)	M.Cap ( in Cr)99314.42
Bharat Parenterals (BSE) 1600.00 (3.42%)	M.Cap ( in Cr)930.56
TTK Healthcare (BSE) 1630.00 (2.43%)	M.Cap ( in Cr)2262.69

Shareholding Pattern

	NON-INSTITUTION	50.74%
	PROMOTERS	30.49%
	MUTUAL FUNDS/UTI	1.71%
	FI/BANKS/INSURANCE	0.04%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Aditya Birla SL Mfg...	0.28
Aditya Birla SL Mid...	0.10
Aditya Birla SL Fle...	0.08
Motilal Oswal S&P B...	0.06

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

SOLARA ACTIVE PHARMA SCIENCES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES